Analysis-Prices for New US Drugs Rose 35% in 2023, More Than the Previous Year Analysis-Prices for New US Drugs Rose 35% in 2023, More Than the Previous Year

Pharmaceutical companies last year launched new U.S. drugs at prices 35% higher than in 2022, reflecting in part the industry ' s embrace of expensive therapies for rare...Reuters Health Information
Source: Medscape Internal Medicine Headlines - Category: Internal Medicine Tags: Family Medicine/Primary Care Source Type: news